Capital Asset Advisory Services LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1666024
Williamston, MI
Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$513,445
-$16,161 QoQ
Shares Held
4,064
+6.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,355
of 2,266 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Asset Advisory Services LLC holds $29,712,872 across 11 Drug Manufacturers - General names. GILD ranks #8 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
26,233 | $6,662,395 | |
| 2 | LLY |
ELI LILLY & Co
|
4,985 | $5,979,159 | |
| 3 | ABBV |
AbbVie Inc.
|
22,814 | $5,740,914 | |
| 4 | PFE |
Pfizer Inc
|
138,613 | $3,337,801 | |
| 5 | MRK |
Merck & Co., Inc.
|
23,955 | $3,078,217 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
46,813 | $2,697,365 | |
| 7 | AMGN |
Amgen Inc
|
1,448 | $524,349 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
4,064 | $513,445 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $513,445 | 4,064 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $529,606 | 3,800 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $450,824 | 3,673 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $396,492 | 3,572 | Shares | Sole | 2025-10-02 | |
| 2025-06-30 | $355,892 | 3,210 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $402,707 | 3,594 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $369,849 | 4,004 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $304,926 | 3,637 | Shares | Sole | 2024-10-17 | |
| 2023-12-31 | $316,263 | 3,904 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $400,629 | 5,346 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $418,875 | 5,435 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $482,470 | 5,815 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $601,636 | 7,008 | Shares | Sole | 2023-03-08 | |
| 2022-09-30 | $507,832 | 8,232 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $636,272 | 10,294 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $536,001 | 9,016 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $639,694 | 8,810 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $608,812 | 8,716 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $668,286 | 9,705 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $598,150 | 9,255 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $605,554 | 10,394 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $871,453 | 13,791 | Shares | Sole | 2020-11-18 | |
| 2020-06-30 | $1,128,402 | 14,666 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,074,749 | 14,376 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||